2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What External and Internal Drivers Are Contributing to the Growth of theCancer Vaccines Market?
The rising global cancer incidence is also expected to contribute to the growth of the cancer vaccines market. In 2022, the American Cancer Society predicted 1.9 million new cancer diagnoses and 609,360 cancer-related deaths in the U.S. alone. The four most prevalent cancers globally—lung, prostate, bowel, and breast cancer—account for a significant portion of new cancer cases. The increasing global cancer rates are expected to drive higher demand for cancer vaccines in the coming years.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3452&type=smp
#How Does the ProjectedCancer Vaccines Market Growth Compare Over the Forecast Period?
The cancer vaccines market size has grown rapidly in recent years. It will grow from $7.22 billion in 2024 to $8.25 billion in 2025 at a compound annual growth rate (CAGR) of 14.3%. The growth is driven by the rising incidence of cancer, expanding approval of cancer vaccines, growing evidence of their efficacy, and government support for research and development.
The cancer vaccines market is set for rapid growth, reaching $13.89 billion by 2029 at a CAGR of 13.9%. The expansion is attributed to combination therapies, increased pharmaceutical investments, emerging biomarkers, personalized vaccines, and expanding vaccination programs. Trends include advancements in immunology, adjuvant therapies, diversification of vaccine indications, patient access, collaborative research, and neoantigen-based vaccines.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3452
How Are Market Trends and Innovations Revolutionizing theCancer Vaccines Industry in Recent Times?
Rising global interest in natural remedies is also expected to affect sales in the cancer vaccines market. Approaches such as Ayurveda, yoga, acupuncture, and sujok therapy are gaining traction and slowly displacing conventional hospital treatments. Ayurvedic methods in particular use a variety of herbal treatments for cancer. As noted by the WHO, many countries continue to rely on plant-based medicine. The homeopathic products market is also forecasted to reach $18.6 billion by 2027. These trends are likely to reduce the demand for cancer vaccines over time.
Who Are the Dominant Market Players Pushing the Boundaries of theCancer Vaccines Market?
Major companies operating in the cancer vaccines market include GlaxoSmithKline plc, Merck & Co. Inc., Aduro Biotech Inc., AstraZeneca PLC, Dendreon Corporation, Astellas Pharma Inc., Sanofi SA, Sanpower Group, CSL Limited, Pfizer Inc., Serum Institute of India Pvt. Ltd., Advantagene Inc., Advaxis Inc., Agenus Inc., Altor BioScience Corporation, Argos Therapeutics Inc., Oncothyreon Inc., Oncovir Inc., Oxford BioMedica plc., Prima BioMed Ltd., Sotio LLC, Transgene SA, Ubivac LLC, Vaccinogen and Vaxon Biotech, Bavarian Nordic A/S, Bharat Biotech International Limited, Bristol-Myers Squibb Company, Dynavax Technologies Corporation, Emergent BioSolutions Inc., Galena Biopharma Inc., Moderna Inc., Biothera Pharmaceuticals Inc., Celldex Therapeutics Inc., Genexine Inc., Gritstone Oncology Inc., Heat Biologics Inc., ISA Pharmaceuticals B.V., Northwest Biotherapeutics Inc., OncBioMune Pharmaceuticals Inc., TapImmune Inc., Vaxil Bio Ltd., VBI Vaccines Inc., Ziopharm Oncology Inc.
https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report
What Are the Core Segments of the Cancer Vaccines Market, and How Do They Contribute to Growth?
The cancer vaccines market covered in this report is segmented –
1) By Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines
2) By Technology: Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines
3) By Cancer Type: Prostate, Cervical, Colorectal, Throat, Other Cancer Types
4) By End-User: Cancer Treatment Centers, Research Institutes
Subsegments:
1) By Preventive Cancer Vaccines: HPV Vaccines, Hepatitis B Vaccines
2) By Therapeutic Cancer Vaccines: Sipuleucel-T (Provenge), Talimogene Laherparepvec (T-VEC), Other Therapeutic Vaccines
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=3452&type=smp
What Regions Are Dominating the Cancer Vaccines Market Growth?
The countries covered in the cancer vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
Browse Through More Reports Similar to the Global Cancer Vaccines Market 2025, By The Business Research Company:
Cancer biologics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report
Veterinary Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report
Companion Animal Veterinary Vaccines Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
